Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
Article in The Annals of Family Medicine (January 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in The Annals of Family Medicine (January 2024)
Article in Journal of Alzheimer's Disease (January 2024)
Article in Frontiers in Neurology (August 2023)